+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Horizon Pharma plc - logo

Horizon Pharma plc is a biopharmaceutical company focused on developing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases. The company markets 11 medicines through its orphan, rheumatology and primary care business units, including ACTIMMUNE, BUPHENYL, DUEXIS, RAVICTI, QUINSAIR and PENNSAID. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.

Market Spotlight: Gout - Product Thumbnail Image

Market Spotlight: Gout

  • Report
  • October 2019
  • 39 Pages
From
Global Gout Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Gout Therapeutics Market 2016-2020

  • Report
  • October 2016
  • 59 Pages
From
From
VIMOVO Drug Profile, 2019 - Product Thumbnail Image

VIMOVO Drug Profile, 2019

  • Report
  • August 2020
  • 114 Pages
From
From
From
From
From
Chronic Back Pain - Pipeline Insight, 2020 - Product Thumbnail Image

Chronic Back Pain - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Chronic Pancreatitis Pain - Pipeline Insight, 2020 - Product Thumbnail Image

Chronic Pancreatitis Pain - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
From
DUEXIS Drug Profile, 2019 - Product Thumbnail Image

DUEXIS Drug Profile, 2019

  • Report
  • August 2020
  • 30 Pages
From
Cystinosis Global Clinical Trials Review, H1, 2019 - Product Thumbnail Image

Cystinosis Global Clinical Trials Review, H1, 2019

  • Clinical Trials
  • April 2019
  • 40 Pages
From
Loading Indicator
adroll